Highlights the possibility of very late malignant pericardial effusion recurrence 25 years after initial breast cancer treatment.
Clinicians should consider malignant effusion in remote breast cancer survivors; this case extends known recurrence latency but is hypothesis-generating.
Pericardial effusion in a patient with a history of cancer should always prompt a hypothesis of malignant involvement. We report the case of a 66-year-old white woman presenting with pericardial effusion 25 years after a mastectomy for ductal breast carcinoma. This is one of the cases with the latest recurrence ever reported.
No takes yet. Share an insight, caveat, or question.
Rovere et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: